Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.32 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12921945 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL7948561 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL12205165 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL6534721 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL13822005 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL423526 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL10045765 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL20844917 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL22472219 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL31384230 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107431-A1 | STEREOSELECTIVE SYNTHESIS OF L,2-CIS-2-AMINOGLYCOSIDES | BRANDEIS UNIVERSITY (US) | 2026-05-21 | — | — | WO | claimed |
| CN-222974877-U | Agricultural composition medicament filling and packaging equipment containing glucose | 眉山百事东旺生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-117343892-B | Construction method and application of artificial lymph node primordium | 中山大学孙逸仙纪念医院 | 2024-04-19 | — | — | CN | claimed |
| CN-117603505-A | Organic/inorganic multi-component composite halogen-free flame retardant, and preparation method and application thereof | 广东石油化工学院 | 2024-02-27 | — | — | CN | claimed |
| CN-117343892-A | Construction method and application of artificial lymph node primordium | 中山大学孙逸仙纪念医院 | 2024-01-05 | — | — | CN | claimed |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| CN-116239711-A | Method for removing SBS homogeneous hydrogenation catalyst in SEBS solution | 华东理工大学 | 2023-06-09 | — | — | CN | claimed |
| CN-116199698-A | Functionalized D-glucal compound and preparation method thereof | 常州大学 | 2023-06-02 | — | — | CN | claimed |
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | DOUBLERAINBOW BIOSCIENCES INC. | 2023-04-20 | — | — | US | claimed |
| US-5191016-A | Functionalized poly(hydroxyalkanoates) and method of manufacturing same | YALPANI MANSSUR (US) | 1993-03-02 | — | — | US | claimed |
| WO-1993003168-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF CARBOHYDRATES | NILSSON KURT (SE) | 1993-02-18 | — | — | WO | claimed |
| EP-0507278-A2 | Immobilised biocatalyser, its preparation and use for ester synthesis in a column reactor | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-07 | — | — | EP | claimed |
| US-5114850-A | Esterification of diol or polyol with acetate, biocatalyst of Corynebacterium | EASTMAN KODAK COMPANY (US) | 1992-05-19 | — | — | US | claimed |
| EP-0463680-A1 | Method for preparing acetate esters of diols and polyols using corynebacterium oxydans in substantially aqueous media | EASTMAN KODAK COMPANY (US) | 1992-01-02 | — | — | EP | claimed |
| EP-0448412-A2 | A route to glycals in the allal and gulal series | YALE UNIVERSITY (US) | 1991-09-25 | — | — | EP | claimed |
| US-4935503-A | One step; using peroxydisulfate, ferrous, azide, and chloride salt | BIOMIRA, INC. (CA) | 1990-06-19 | — | — | US | claimed |
| EP-0340780-A2 | Azidochlorination and diazidization of glycals | BIOMIRA, INC. (CA) | 1989-11-08 | — | — | EP | claimed |
| US-4218535-A | Determination of enzyme substrate concentration | BECKMAN INSTRUMENTS, INC. (US) | 1980-08-19 | — | — | US | claimed |
| US-4195174-A | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | CHEMBIOMED LTD. (CA) | 1980-03-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | UGGT1, UGDH, GALE | FUCA1 7/4885L3MBTL1 1359/4885ALDH1A1 395/4885 |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | UGDH, IDH1, G6PD | FUCA1 31/4885L3MBTL1 1574/4885ALDH1A1 292/4885 |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | GALE, UGGT1, DERA | FUCA1 8/4885L3MBTL1 1063/4885ALDH1A1 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.